Sign In
Buy XNCR
$20.21
-1.28 (-5.96%)
At Close: Jul 31, 2026
Strength Seen in 4D Molecular Therapeutics, Inc. (FDMT): Can Its 16.0% Jump Turn into More Strength?
03:58pm, Friday, 28'th Oct 2022 Zacks Investment Research
4D Molecular Therapeutics, Inc. (FDMT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest furth
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
02:05pm, Thursday, 13'th Oct 2022 Benzinga
Upgrades
TD Securities upgraded the previous rating for BCE Inc (NYSE:BCE) from Hold to Buy. In the second quarter, BCE showed an EPS of $0.68, compared to $0.68 from the year-ago quarter. The current
Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting
08:01am, Wednesday, 05'th Oct 2022
MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune dise
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
02:04pm, Wednesday, 21'st Sep 2022 Benzinga
Upgrades
For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q2 2022 Results Earnings Call Transcript
11:28pm, Wednesday, 03'rd Aug 2022
Xencor, Inc. (NASDAQ:XNCR ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Charles Liles - Head, Corporate Communications and IR Bassil Dahiyat - President and CEO All
Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates
09:25pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Xencor (XNCR) delivered earnings and revenue surprises of -26.67% and 12.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates
06:48pm, Wednesday, 03'rd Aug 2022
Xencor (XNCR) delivered earnings and revenue surprises of -26.67% and 12.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Xencor: Capital-Efficient Platform Tech Play With A Lot Going On
12:49pm, Friday, 03'rd Jun 2022
Shares of Xencor have fallen by 46% since my 2019 update. I initially liked this one for "picks and shovels" aspect of the story. XmAb technology is being utilized by a variety of big pharmaceutical c
7 High-Risk, High-Reward Small-Cap Stocks to Buy Now
09:18am, Friday, 13'th May 2022
Many small-cap stocks in the S&P 600 Small Cap Index aren't big names, but they have the change of bringing big rewards. The post 7 High-Risk, High-Reward Small-Cap Stocks to Buy Now appeared first on
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2022 Results - Earnings Call Transcript
03:09am, Sunday, 08'th May 2022
Xencor, Inc. (NASDAQ:XNCR ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Charles Liles - Head, Corporate Communications and Investor Relations Bassil Dahiyat - Presiden
Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues
02:24pm, Friday, 06'th May 2022 Zacks Investment Research
Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates. The company maintains revenue guidance for 2022. Stock declines
Zacks.com featured highlights Xencor, Encore Wire and Silvergate Capital
09:38am, Friday, 06'th May 2022 Zacks Investment Research
Xencor, Encore Wire and Silvergate Capital have been highlighted in this Screen of The Week article.
Xencor (XNCR) Beats Q1 Earnings and Revenue Estimates
09:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Xencor (XNCR) delivered earnings and revenue surprises of 155.71% and 302.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Xencor (XNCR) Beats Q1 Earnings and Revenue Estimates
06:48pm, Thursday, 05'th May 2022
Xencor (XNCR) delivered earnings and revenue surprises of 155.71% and 302.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y
03:26pm, Thursday, 05'th May 2022 Zacks Investment Research
Pacira's (PCRX) earnings fall shy of estimates in the first quarter of 2022 while revenues beat the same.
